Literature DB >> 6140979

Dopamine and depression: a review of recent evidence. I. Empirical studies.

P Willner.   

Abstract

This paper reviews evidence from human, predominantly clinical, studies, relevant to the hypothesis that depression involves reduced levels of dopamine (DA) function. With the exception of Parkinson's disease, there is little evidence that treatments which decrease DA function are potent inducers of depression, but it is argued that such a relationship might not necessarily be expected. There is good evidence that the nigro-striatal DA system is underactive in retarded depressions, and some evidence that DA agonists are therapeutically effective in these cases. It remains unclear whether changes in DA function are primary or secondary.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140979     DOI: 10.1016/0165-0173(83)90005-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  44 in total

Review 1.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

2.  Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain.

Authors:  T Kobayashi; K Matsuno; M Murai; S Mita
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

Review 3.  Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

Authors:  Horrick Sharma; Soumava Santra; Aloke Dutta
Journal:  Future Med Chem       Date:  2015-11-30       Impact factor: 3.808

Review 4.  [Antidepressant effects of dopamine agonists. Experimental and clinical findings].

Authors:  M R Lemke
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 5.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 6.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

Review 7.  Basal ganglia circuit loops, dopamine and motivation: A review and enquiry.

Authors:  Satoshi Ikemoto; Chen Yang; Aaron Tan
Journal:  Behav Brain Res       Date:  2015-04-20       Impact factor: 3.332

8.  Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice.

Authors:  Kohei Tanaka; Tomoyuki Furuyashiki; Shiho Kitaoka; Yuta Senzai; Yuki Imoto; Eri Segi-Nishida; Yuichi Deguchi; Richard M Breyer; Matthew D Breyer; Shuh Narumiya
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

Review 9.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

10.  Frequency-dependent block of field potentials in the rat hippocampal slice caused by tricyclic antidepressants.

Authors:  R Anwyl; M J Rowan
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.